anonymous
Guest
anonymous
Guest
what do you want to knowTell us more friend
what do you want to knowTell us more friend
Tell us what’s not so common about Hugo?the new CEO will have to make the decision to put Hugo down. Sunk cost fallacy has taken over common sense.
No new CEO coming anytime soon. Geoff is a rockstarthe new CEO will have to make the decision to put Hugo down. Sunk cost fallacy has taken over common sense.
Did anyone guess the ENTIRE Linq team?
Wow, that’s a lot of people.
I’m looking to leave Surgical. Sinking Titanic. I won’t be left playing the violinNo new CEO coming anytime soon. Geoff is a rockstar
lol - not the first business that would come to my mind personally…CST should be sold. Zero innovation
Contego Medical distribution has entered the chatPV doesn't have anything in the hopper. Here's the Q1 results -- " Peripheral Vascular Health grew low-single digits, with high-single digit growth in drug-coated balloons and low-single digit growth in endoVenous products"
They are crushing us in PFA because our management knows nothing about manufacturing. I mean CRUSHING us in a huge market that now makes up 56% of AFib treatments.Contego Medical distribution has entered the chat
Meanwhile BSci has totally flubbed their Silk Road acquisition. Perfect timing
Diabetes - Blackstone is fucking pissed and Q is an incompetent moron
InspireMD has entered the chatContego Medical distribution has entered the chat
Meanwhile BSci has totally flubbed their Silk Road acquisition. Perfect timing
We hope she gets what she deservesDiabetes - Blackstone is fucking pissed and Q is an incompetent moron
Why would MDT spin Diabetes off? It’s one of the main growth drivers - GM speaks of in town halls.We hope she gets what she deserves
It may not be fully up to them. It may ultimately be the board + Blackstone combo - again both are (rightfully) PISSED and it is a lot easier for a syndicate of buyout PE funds to come in, slash 50% of the people in that division, reposition and focus the portfolio (which is already in motion post Abbott announcement and failure in Simplera), and MDT as a mothership just isn't built to make the changes that need to be made to make it competitive. The core issue is they are getting their ass handed to them by Insulet and I have to be careful here, but those of you who have worked on the patch pump "program" know the difference between the delusion and incompetence of Q and GM vs. the reality that we're likely going to place our bets on a shitty Medingo reboot out of Israel unless Blackstone/BOD step in to stop the charlatan over at Medtronic Israel that is Yaron Itzhari.Why would MDT spin Diabetes off? It’s one of the main growth drivers - GM speaks of in town halls.
InspireMD has entered the chat